-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MRTX-9768 in Non-Small Cell Lung Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MRTX-9768 in Non-Small Cell Lung Cancer Drug Details:MRTX-9768 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ketamine in Binge Eating Disorder
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ketamine in Binge Eating Disorder Drug Details:Ketamine is under development for the treatment of alcohol use...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ensomafusp Alfa in Marginal Zone B-cell Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ensomafusp Alfa in Marginal Zone B-cell Lymphoma Drug Details: Ensomafusp alfa (RG-6076, RO-7227166) is under...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – VH-4004280
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry VH-4004280 Drug Details VH-4004280 is under development for the treatment of human immunodeficiency virus...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – VH-4011499A
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry VH-4011499A Drug Details VH-4011499A is under development for the treatment of human immunodeficiency virus...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – (dolutegravir + GSK3640254)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (dolutegravir + GSK3640254) Drug Details Dolutegravir in fixed dose combination with GSK-3640254 is under...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – VH-3810109
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry VH-3810109 Drug Details GSK-3810109 is under development for the treatment of human immunodeficiency virus...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – VH-3739937
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry VH-3739937 Drug Details GSK-3739937 is under development for the treatment of human immunodeficiency virus...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – GSK-3640254
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry GSK-3640254 Drug Details GSK-3640254 is under development for the treatment of human immunodeficiency virus...
-
Product Insights
![]()
Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Transdermal drug delivery devices is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal drug delivery pipeline market research report provides comprehensive information about the transdermal drug delivery devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.